Ontology highlight
ABSTRACT: Background
Chimeric antigen receptor (CAR) T cell therapy has shown remarkable success in hematologic malignancies but faces substantial challenges in solid tumors. One of the main obstacles is the extracellular matrix (ECM), which serves as the physical barrier that hinders T cell infiltration into tumor tissues.Methods
We engineered CAR-T cells targeting mesothelin or B7H3 to co-express matrix metalloproteinase-3 (MMP3). We evaluated the effects of MMP3 overexpression on CAR-T cell proliferation, activation, cytotoxicity, and tumor infiltration using both in vitro Matrigel-based assays and in vivo xenograft and syngeneic models enriched with cancer-associated fibroblasts (CAFs).Results
MMP3 overexpression did not impair CAR-T cell proliferation, activation, or cyt
SUBMITTER: Zhu Y
PROVIDER: S-EPMC12853521 | biostudies-literature | 2026 Jan
REPOSITORIES: biostudies-literature